# Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients

> **NCT02542631** · NA · COMPLETED · sponsor: **Calibra Medical, Inc.** · enrollment: 278 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DEVICE:** Bolus Insulin Patch (Calibra Finesse)
- **DEVICE:** Insulin Pen (Novo-Nordisk FlexPen®)

## Key facts

- **NCT ID:** NCT02542631
- **Lead sponsor:** Calibra Medical, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08-01
- **Primary completion:** 2017-08-31
- **Final completion:** 2017-08-31
- **Target enrollment:** 278 (ACTUAL)
- **Last updated:** 2025-02-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02542631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02542631, "Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02542631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*